Science News

... from universities, journals, and other research organizations

Ginseng Reduces Effects Of Anti-Clotting Drug

July 6, 2004 — Researchers from the University of Chicago report in the July 6, 2004, issue of the Annals of Internal Medicine that ginseng, one of the best selling herbal supplements in the United States, interferes with warfarin, a drug commonly used to prevent blood clots.


Share This:

The researchers encourage anyone who takes both ginseng and warfarin, also known as Coumadin®, to notify his or her doctor and urged doctors to ask patients on warfarin if they are taking ginseng.

"Warfarin has a narrow therapeutic index," said study author Chun-Su Yuan, M.D., Ph.D., "which means precise dosing is crucial."

"With too small a dose," added Yuan, the Cyrus Tang Professor of Anesthesia & Critical Care and director of the Tang Center for Herbal Medicine Research at the University of Chicago, "the risk of clots increases, but too much can cause serious bleeding. So a substance, such as ginseng, that alters warfarin's effects, even slightly, can have significant consequences."

The 'blood-thinner' warfarin, taken once a day by about 3 million people in the U.S., is used to prevent blood clots from forming or growing larger. It is often prescribed for patients with certain types of irregular heartbeat, those who have had a heart attack or undergone heart valve replacement surgery. It prevents the formation of substances that cause clots.

Package inserts stress the importance of maintaining the proper dose. "It cannot be emphasized too strongly," notes the insert, "that treatment of each patient is a highly individualized matter. Warfarin sodium, a narrow therapeutic range drug, may be affected by factors such as other drugs and dietary Vitamin K. Dosage should be controlled by periodic determinations of prothrombin time," a measure of clotting speed.

Yuan's team studied 20 healthy volunteer subjects for four weeks. All subjects received 5 mg a day of warfarin for three days during week one and again in week four. Beginning in week two, 12 subjects took two grams of powdered ginseng in capsules. The other eight volunteers received a placebo. The researchers monitored blood levels of warfarin and the clotting ability of the blood.

They found that after two weeks, daily doses of ginseng significantly reduced the blood levels and the anti-clotting effects of warfarin.

Since ginseng alone can promote bleeding and delay clot formation, the researchers were surprised to find that it reduced the anti-clotting effect of warfarin compared to those who took the placebo. They suspect that substances within ginseng may enhance the function of enzymes that break down warfarin, clearing it from the blood stream more rapidly.

The National Institutes of Health and the Tang Center for Herbal Medicine Research funded this study. Additional authors include Gang Wei, Lucy Dey, Theodore Karrison, Linda Nahlik, Spring Maleckar, Kristen Kasza, Michael Ang-Lee and Jonathan Moss of the University of Chicago.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by University Of Chicago Medical Center.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,193

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


Breathing Easier

Half of all lung transplant patients don't live past the fifth year after the procedure, due in part to chronic rejection of the new organs. A new,. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: